US Corporate Distress Financial Stress SEC Filings — July 08, 2026

08-07-2026

XCF Global, Inc. entered into a $1,000,000 senior secured promissory note with Brown Stone Capital Limited on July 1, 2026, receiving net proceeds of $750,000 after a 25% original issue discount. The loan carries a 10% annual interest rate, a two-month term, and requires mandatory prepayments from revenue and asset sale proceeds, while also issuing 500,000 shares of common stock as a commitment fee and reserving 5,000,000 Default Shares. This financing provides short-term liquidity but at a high cost, with no positive or negative performance metrics to balance—only the terms themselves indicate financial strain.

• · Loan term is non-amortizing with a two-month maturity (60 days after funding).
• · Optional prepayment is allowed without penalty.
• · Security interest covers inventories, accounts, environmental attributes, deposit and securities accounts, equipment, chattel paper, and proceeds of XCF Global, Inc. only—not its subsidiaries.
• · Loan is not guaranteed by any of the Company's subsidiaries.
• · Default Shares (5,000,000) are authorized but unissued shares to be issued immediately upon an Event of Default.

08-07-2026

Ivanhoe Electric Inc. entered into an Amended and Restated Shareholders Agreement with Saudi Arabian Mining Company (Maaden) on July 7, 2026, governing their 50/50 joint venture in Saudi Arabia. The new agreement extends the exploration term to July 6, 2033 (from an initial five-year term), allows the joint venture to acquire exploration and mining licenses directly, and grants the technical committee more authority. However, the agreement also imposes a non-compete clause on Ivanhoe Electric in Saudi Arabia without Maaden's consent, and Maaden retains significant governance rights including the ability to nominate a director to Ivanhoe Electric's board.

• · The joint venture board chairperson will be chosen from among Maaden's nominees.
• · Maaden will assume operatorship if an economically viable deposit is found and designated for development.
• · If Ivanhoe Electric chooses not to participate in a Designated Project, it may engage Maaden in discussions regarding transfer or exchange of its interest for fair market value, possibly including a royalty.
• · The joint venture is not terminable by either party before the end of the exploration phase except upon an event of default.
• · Upon termination, Typhoon™ units will be returned to Ivanhoe Electric, but Maaden has the right to negotiate continued services for exploring other Maaden land.
• · Maaden beneficially owns greater than 5% of Ivanhoe Electric's common stock and has the right to nominate one director to Ivanhoe Electric's board.

08-07-2026

Aethlon Medical announced a $4.0 million follow-on offering priced at-the-market under Nasdaq rules, issuing 5,633,009 shares (or pre-funded warrants) and accompanying warrants at $0.7101 per unit. The company intends to use net proceeds for general corporate purposes including R&D, clinical trials, and potential acquisitions. The offering closed on July 7, 2026, but the warrants require stockholder approval before exercisability, introducing execution risk.

• · The warrants have an exercise price of $0.7101 per share, exercisable upon stockholder approval, and expire five years from that date.
• · Maxim Group LLC is the sole placement agent.
• · The offering is made under a Form S-1 registration statement (File No. 333-296933) declared effective on July 6, 2026.
• · The Hemopurifier holds FDA Breakthrough Device designation for advanced/metastatic cancer and life-threatening viruses.

08-07-2026

Civeo Corporation completed a private offering of $100 million aggregate principal amount of 4.50% Convertible Senior Notes due 2031, receiving net proceeds of approximately $96.2 million. The company used $22.3 million of the proceeds to repurchase 660,297 of its common shares and intends to use the remainder to repay outstanding borrowings under its credit facility. The notes are convertible into common shares at an initial conversion price of approximately $40.51 per share, and the offering was conducted as an unregistered transaction under Rule 144A.

• · The notes bear interest at 4.50% per annum, payable semi-annually on February 1 and August 1, starting February 1, 2027.
• · The notes mature on August 1, 2031, unless earlier repurchased, redeemed, or converted.
• · The company may not redeem the notes prior to August 1, 2029, except for tax or cleanup redemptions.
• · Holders may convert notes under certain conditions, including if the stock price exceeds 130% of the conversion price for 20 trading days in a 30-day period.
• · Upon a fundamental change, holders may require the company to repurchase the notes at 100% of principal plus accrued interest.
• · The indenture includes customary events of default, including delisting events.

08-07-2026

AmpliTech Group, Inc. terminated its Equity Distribution Agreement with Maxim Group LLC effective July 7, 2026, and simultaneously announced a $10 million stock repurchase program authorized by its Board of Directors to be executed over 24 months. The termination of the at-the-market offering agreement removes a potential dilutive capital source, while the buyback program signals management's confidence but is discretionary and non-binding.

• · The Equity Distribution Agreement was originally dated March 21, 2025.
• · The repurchase program may be executed through open market purchases, privately negotiated transactions, block trades, or other means.
• · The company may enter into a trading plan under Rule 10b5-1.
• · The program does not obligate the company to repurchase any specific number of shares and can be suspended, modified, or discontinued at any time without notice.

08-07-2026

AEP Texas, a subsidiary of American Electric Power, has secured a $3.26 billion loan from the U.S. Department of Energy's Office of Energy Dominance Financing to fund nearly 100 grid infrastructure projects. The investment is expected to save customers $685 million over 30 years, support up to 41 GW of new load additions through 2030, and rebuild or reconductor approximately 2,800 miles of transmission lines. This initiative aims to enhance reliability and manage affordability in one of the fastest-growing U.S. regions.

• · AEP Texas is an energy delivery (wires) company operating in the deregulated Texas retail electric marketplace.
• · The loan is part of AEP's broader strategy across its 11-state service territory to secure federal funding to reduce customer costs while supporting growth and investing in reliability and resiliency.
• · AEP Texas also builds new power lines, restores service following outages, reads meters via advanced meter technology, and connects/disconnects service upon orders from retail electric providers.

08-07-2026

Byrna Technologies Inc. (BYRN) has entered into a definitive agreement to acquire substantially all assets of HERO Defense Systems, LLC for $1.25 million total consideration ($625,000 cash + $625,000 restricted stock) plus a performance-based royalty on future net sales. The strategic bolt-on acquisition adds compact everyday-carry personal defense products (HERO 2020 and AIIRO) to expand Byrna's product portfolio into smaller form factors and lower price points, with closing expected within 30 days. While the acquisition is small in absolute size, it is strategically positioned to broaden Byrna's addressable market and create a lower-friction entry point for new consumers, though integration risks and potential dilution from the restricted stock issuance remain considerations.

• · Transaction is structured as an asset purchase on a cash-free, debt-free basis.
• · Consideration includes a performance-based royalty tied to future net sales of HERO products and derivative products.
• · Restricted shares will be issued in a private placement under an exemption from the Securities Act of 1933 and will be subject to transfer restrictions.
• · HERO's founders are expected to provide transition and integration support following closing.
• · Byrna plans to evaluate opportunities to support HERO products through Byrna.com, Amazon, and retail merchandising.
• · The acquisition is subject to customary closing conditions and expected to close within approximately 30 days.
• · The filing includes forward-looking statements regarding integration, regulatory approvals, and market expansion risks.

08-07-2026

Newton Golf Company, Inc. (NWTG) entered into a Loan and Security Agreement with Brynwood, LLLP for a senior secured revolving credit facility of up to $5.0M with Daily Simple SOFR plus 13% interest, maturing on an unstated date. The agreement allows semi-annual interest payments and includes a 2% commitment fee, but carries a steep default rate of 22%, reflecting high financing costs for the borrower.

• · Borrower must provide an unconditional promise to pay principal and accrued interest.
• · Advances are subject to a minimum of $200,000 per borrowing.
• · Repayment and reborrowing are allowed during the availability period with no prepayment penalty.
• · Borrower may permanently reduce the commitment in increments of at least $250,000.
• · Interest is computed on a 360-day year for actual days elapsed.
• · A 2% commitment fee ($100,000) is due on the effective date or deducted from the initial advance.
• · Borrower grants a continuing security interest in all collateral, now owned or later acquired.
• · Borrower must pay all Lender expenses, including enforcement costs after an event of default.
• · Any borrowing request constitutes a release of claims against Lender existing prior to that request.
• · Conditions precedent include delivery of organizational documents, UCC searches, and no existing default.
• · The Maturity Date and Availability Period are not specified in the excerpt.

08-07-2026

Alector, Inc. (ALEC) announced the termination of its collaboration agreement with GSK following the failure of two key clinical trials: the Phase 3 INFRONT-3 trial for latozinemab in frontotemporal dementia and the Phase 2 PROGRESS-AD trial for nivisnebart in early Alzheimer's disease. The GSK Agreement will terminate effective January 2, 2027. Additionally, the company repaid and terminated its loan agreement with Hercules Capital, repaying $10.4 million in principal plus accrued interest and charges.

• · The Phase 3 INFRONT-3 trial for latozinemab did not meet its clinical co-primary endpoint (announced October 21, 2025).
• · The Phase 2 PROGRESS-AD trial for nivisnebart was discontinued after an interim futility analysis (announced April 29, 2026).
• · The GSK Agreement termination is effective 180 days from July 6, 2026, i.e., January 2, 2027.
• · The loan repayment included accrued interest and end-of-term and prepayment charges.

08-07-2026

Phoenix Energy One, LLC entered into an indenture on July 7, 2026, to issue up to $100,000,000 in Senior Subordinated Junior Lien Notes, registered under an effective S-1 filing. The Notes carry interest rates of 6.00% to 7.00% per annum, mature in 10 years, and are subordinated to the company's senior debt under the Fortress Credit Agreement. No financial performance or prior period data is provided in this filing.

• · The offering is registered on Form S-1 (File No. 333-296428) declared effective July 7, 2026.
• · Notes are secured on a junior basis, with the intercreditor agreement granting Fortress exclusive remedy rights over shared collateral until first lien obligations are discharged.
• · No subsidiary or affiliate guarantees the Notes.
• · Holders may request redemption on Set Put Dates at 100% of principal plus accrued interest, with notice required 30-45 days prior.
• · Covenant requires the company to maintain a Loan-to-Value Ratio of 1.00 to 1.00.
• · Events of default include a 60-day cure period for payment defaults and a 120-day cure period for other covenant breaches.

08-07-2026

Canadian Pacific Kansas City Limited (CP) entered into a Second Amending Agreement on July 6, 2026, extending the maturity dates of its credit facilities. The 5 Year Facility maturity was extended from June 25, 2030 to June 25, 2031, and the 2 Year Facility maturity was extended from June 25, 2027 to June 25, 2028. This amendment provides the company with additional long-term financial flexibility.

• · The Second Amending Agreement amends the third amended and restated credit agreement dated June 25, 2024.
• · The 5 Year Facility maturity was extended by one year to June 25, 2031.
• · The 2 Year Facility maturity was extended by one year to June 25, 2028.
• · The amendment was entered into by Canadian Pacific Railway Company (borrower), Canadian Pacific Kansas City Limited (covenantor), and Bank of Montreal (administrative agent).

08-07-2026

Borealis Foods Inc. received a Nasdaq notice on July 2, 2026, for failing to meet the minimum Market Value of Listed Securities (MVLS) requirement of $35,000,000 for continued listing on the Nasdaq Capital Market. The company has a 180-day compliance period until December 29, 2026, to regain compliance, but also does not currently satisfy alternative listing standards based on stockholders' equity or net income. There is no immediate impact on trading, but failure to regain compliance could lead to delisting of both common shares and warrants.

• · The company does not currently satisfy alternative continued listing standards under Nasdaq Listing Rules 5550(b)(1) (stockholders' equity) and 5550(b)(3) (net income from continuing operations).
• · If common shares are delisted, the warrants (BRLSW) would also cease to be listed.
• · The company intends to monitor market value and consider available options, but there is no assurance of regaining compliance.

08-07-2026

On July 1, 2026, Alliance Resource Partners, L.P. (ARLP) through its wholly owned subsidiary Matrix Design Africa (PTY) LTD entered into a Master Supply, Distribution and Services Agreement with Saminco Solutions LLC, a company affiliated with ARLP’s President and CEO, Joseph W. Craft III, who beneficially owns approximately 14.6% of ARLP's common units. The agreement grants distribution rights for certain products in Africa and other non-U.S. territories, allows product purchases and services, and includes a five-year initial term with automatic one-year renewals. The related-party transaction was reviewed and approved by the Conflicts Committee of the Board, which determined it to be fair and reasonable to ARLP and its unitholders. No financial terms or quantitative amounts were disclosed in this filing.

• · The Supplier, Saminco Solutions LLC, is affiliated with Joseph W. Craft III, who is also the President and CEO of ARLP's managing general partner and beneficially owns about 14.6% of ARLP's common units.
• · The agreement allows the Customer to serve as non-exclusive distributor in Africa and other non-U.S. territories for Supplier's products, and purchase products and services (including repair/refurbishment).
• · The Supplier also has a non-obligatory right to purchase products from the Customer for incorporation into its own products for resale.
• · Prices for products and services must be no less favorable to the Customer than those extended to similarly situated customers of the Supplier.
• · The agreement may be terminated without cause by either party upon at least 90 days' notice; the Customer can cancel purchase orders under certain circumstances including Supplier non-performance.

08-07-2026

Tarsus Pharmaceuticals acquired iRenix Medical for $75 million in upfront consideration ($37.5M cash + $37.5M stock) plus up to $490 million in milestone payments, adding late-stage asset IRX-101 for reducing post-intravitreal injection pain and corneal toxicity. IRX-101 has positive Phase 2b/3 data showing a ~50% relative reduction in pain and ~25% reduction in corneal staining versus povidone-iodine, with an FDA-aligned Phase 3 program expected to start in H1 2027 with results in 2028. The deal targets the >11 million annual U.S. intravitreal injection market where no new FDA-approved ocular antiseptic has emerged in over 40 years, but carries significant development, regulatory, and commercial risk.

• · Phase 3 study expected to begin enrollment in H1 2027, results anticipated in 2028.
• · p-value for pain reduction: 0.0003; p-value for corneal staining: 0.0003.
• · Half of patients in IRX-101 group reported a pain score of zero.
• · Povidone-iodine is contraindicated in iodine-sensitive patients.
• · Tarsus to host investor conference call on July 8, 2026 at 1:30 p.m. PT / 4:30 p.m. ET.
• · Transaction advisors: Gunderson Dettmer for Tarsus; Piper Sandler (financial) and DLA Piper (legal) for iRenix.
• · Full merger agreement to be filed as an exhibit with Form 10-Q for quarter ending September 30, 2026.

08-07-2026

Voyager Technologies, Inc. entered into a Fourth Amendment to its Credit Agreement on July 6, 2026, increasing its revolving commitments by $50 million to a total of $500 million (as inferred from the existing $450 million base plus the incremental $50 million). The amendment was led by JPMorgan Chase as lead arranger and bookrunner, and required consent from lenders representing the required majority. The company paid a 0.05% consent fee to participating lenders and satisfied standard conditions including legal opinions, solvency certificates, and no event of default.

• · The amendment was the fourth modification to the original Credit Agreement dated May 30, 2025, following prior amendments on September 18, 2025, October 22, 2025, and November 10, 2025.
• · Conditions included receipt of legal opinions, organizational documents, incumbency certificates, board resolutions, good standing certificates, and a solvency certificate.
• · No Default or Event of Default existed as of the effective date.
• · The amendment did not constitute a novation; existing obligations remained in full force.

08-07-2026

Sadot Group Inc. entered into two Debt Settlement and Share Issuance Agreements on July 7, 2026, to settle outstanding indebtedness of $1,876,500 to Cedar Advance LLC and $1,482,912.50 to Agile Capital Funding, LLC and Agile Lending LLC by issuing 45,000 shares of common stock to each creditor (90,000 shares total). No cash consideration was paid; the shares represent approximately 9% of outstanding common stock post-issuance. The settlements were conducted under exemptions from registration under the Securities Act.

• · The Settlement Agreements are governed by the laws of the State of Nevada.
• · The shares were issued in reliance on exemptions under Section 3(a)(9) and/or Section 4(a)(2) of the Securities Act.
• · Each creditor represented that it is an accredited investor.
• · The settlement shares have not been registered under the Securities Act and are subject to restrictions on resale.

08-07-2026

Invitation Homes Inc. (INVH) announced the closing of an underwritten public offering of $500 million aggregate principal amount of 4.950% Senior Notes due 2032 by its operating partnership. The notes are fully and unconditionally guaranteed by the parent company and other guarantors, and were issued at 98.691% of par. The issuance represents a refinancing or capital markets activity with no associated period-over-period performance data.

• · Notes mature on February 1, 2032.
• · Interest payable semi-annually on February 1 and August 1, commencing February 1, 2027.
• · Prior to January 1, 2032 (Par Call Date), the issuer may redeem at the greater of 100% of principal plus accrued interest or the present value of remaining payments discounted at Treasury Rate plus 15 basis points.
• · On or after the Par Call Date, the issuer may redeem at 100% of principal plus accrued interest.
• · Events of default include 30-day interest payment default, principal payment default, failure to comply with covenants (60-day cure), cross-default on other debt over $50 million (60-day cure), and bankruptcy of the issuer or any guarantor.
• · The offering was made under an effective shelf registration statement filed June 14, 2024 (Registration Nos. 333-280210, 333-280210-01, 333-280210-02, 333-280210-03) and a prospectus supplement dated June 30, 2026.
• · The notes are senior unsecured obligations and are effectively subordinated to all existing and future secured indebtedness and liabilities of non-guarantor subsidiaries.

08-07-2026

Netcapital Inc. CEO Todd Violette provided a shareholder update outlining a strategic shift from a standalone Regulation Crowdfunding portal to a comprehensive ecosystem integrating education, advisory, data analytics, and broker-dealer services. The company is developing 'Project Orion,' a private AI operating environment, and is actively evaluating data center acquisitions to support its technology infrastructure. No financial results or specific performance metrics were disclosed, and the update emphasized that these initiatives are in early evaluation stages with no definitive agreements.

• · The company is evaluating acquisitions of data center assets and infrastructure to support AI computing requirements, but these are in early evaluation stages and subject to board approval and regulatory processes.
• · Netcapital operates a regulated funding portal and a FINRA-registered broker-dealer, which are viewed as the foundation for a larger ecosystem.
• · The update explicitly states it is not a financial earnings call and contains forward-looking statements with no obligation to update.

08-07-2026

Contango ORE, Inc. amended its credit facility to convert the remaining 15,000 ounces of hedged gold into $33.0M of debt, eliminating the ceiling on future gold price exposure. The interest rate was reduced from ~8.9% to ~7.40%, and the total principal increased from $12.6M to $46.3M with scheduled repayments through June 2027. While the company is bullish on gold and expects a record 2027, the debt load has significantly increased and the Manh Choh mine is in a transitional phase between pits.

• · The company paid $715,000 to purchase 15,000 put contracts with a $3,100/oz strike price as a price protection strategy.
• · Manh Choh mine is transitioning from North Pit to South Pit, with higher-grade campaigns expected to finish 2026.
• · The company retains flexibility to repay the debt at any time and is focused on paying down the credit facility ahead of schedule.
• · No restructuring fee was incurred for the amendment.

08-07-2026

GoPro announced that founder and CEO Nicholas Woodman will provide $20 million in financing through senior secured notes and warrants, a move approved by an independent board committee. The financing reflects Woodman's confidence in GoPro's opportunities, but the company continues to evaluate strategic alternatives announced on May 11, 2026, and faces risks including potential dilution and liquidity concerns.

• · The financing is subject to certain closing conditions.
• · The independent committee evaluated a range of financing options and concluded this structure offered the most favorable terms.
• · The strategic alternatives review process was announced on May 11, 2026, and continues to progress.
• · Risks include potential dilutive effect of warrants and other equity-linked securities on existing stockholders.
• · The financing is a related-party transaction, which carries inherent risks.

08-07-2026

Nocera, Inc. announced a 1-for-30 reverse stock split effective July 6, 2026, to increase its share price and maintain Nasdaq listing compliance. The split reduces outstanding shares from 46,495,187 to approximately 1,549,956, while proportionate ownership remains unchanged. The move supports Nocera's transformation into a diversified technology holding company, but the high split ratio signals ongoing stock price weakness and potential delisting risk.

• · The reverse stock split was authorized by stockholders at the January 12, 2026 annual meeting under Proposal No. 4, authorizing a range between 1-for-5 and 1-for-100.
• · The Board selected the 1-for-30 ratio on June 25, 2026, within the stockholder-approved range.
• · No fractional shares will be issued; holders receive cash equal to fractional share interest multiplied by Nasdaq closing price on the last trading day before effectiveness.
• · Proportionate adjustments will be made to per share exercise prices and numbers of shares issuable upon exercise of all outstanding stock options and warrants, and to restricted stock units and equity incentive plan reserves.
• · New CUSIP number following the reverse split: 655186609.
• · The Company intends to use the higher share price to facilitate acquisitions, partnerships, and investments under its holding company strategy, including the previously announced minority equity investment in CampaignPulse.ai.

08-07-2026

ReposiTrak, Inc. entered a stock purchase agreement with William Bartels to acquire 4,016,812 shares of SPAR Group, Inc. for $0.70 per share, totaling $2,811,768. The deal includes a $100,000 non-refundable deposit, a $139,883 closing payment, and a $2,571,885 promissory note. ReposiTrak retains the right to terminate the agreement for any reason before closing, in which case the deposit is kept by the seller as liquidated damages.

• · The agreement includes a no-public-announcement clause until after the closing or as required by securities laws.
• · The promissory note accelerates upon the seller's death, with proceeds payable to heirs within 60 days of proof of death.
• · ReposiTrak explicitly disclaims intent or ability to control SPAR Group, Inc. post-purchase.
• · The agreement is governed by Utah law, with exclusive jurisdiction in Utah courts and a jury trial waiver.
• · Seller retains termination fee (deposit) as liquidated damages if buyer terminates for any reason.

08-07-2026

Aimei Health Technology Co., Ltd. (NASDAQ: AFJK, AFJKU, AFJKR) terminated its Business Combination Agreement with United Hydrogen Group Inc., originally dated June 19, 2024 and amended on June 6, 2025, because the closing was not completed by the applicable outside date. The termination was effective immediately upon delivery of notice on July 7, 2026. While the company expressed confidence in pursuing a future transaction, the termination represents a failed deal and a setback in its SPAC merger timeline.

• · The Business Combination Agreement was originally dated June 19, 2024 and amended on June 6, 2025.
• · Termination notice was delivered on July 7, 2026, effective immediately.
• · Termination was triggered by the occurrence of the applicable outside date under Section 9.1(b) of the agreement.
• · The company's CEO stated they remain confident in identifying and executing a compelling transaction in the future.

08-07-2026

Clean Energy Technologies, Inc. (CETY) entered into a Securities Purchase Agreement with Coventry Enterprises LLC on June 29, 2026, issuing a $166,500 promissory note (including $16,500 original issue discount) in a private placement exempt from SEC registration. The company has 12,166,106 shares outstanding and authorized 2,000,000,000 shares of common stock. The filing does not disclose any period-over-period financial performance data, so no comparisons are available.

• · The note includes a $16,500 original issue discount, reducing net proceeds to the company.
• · The company has a $6,000 brokerage obligation to Carter, Terry and Company, Inc. related to the transaction.
• · The securities are unregistered and bear a restrictive legend; removal requires registration or a legal opinion.
• · No material adverse change has occurred since December 31, 2025, according to company representations.

08-07-2026

Future FinTech Group Inc. (FTFT) filed Articles of Amendment to effect a 1-for-4 reverse stock split and reduce authorized common shares from 150,000,000 to 37,500,000, a proportional 75% reduction. The split is intended to regain compliance with Nasdaq listing requirements, with the market effective date expected shortly after Nasdaq confirmation. No shareholder approval was required under Florida law.

• · The reverse stock split was adopted by the Board of Directors on June 17, 2026, without shareholder action.
• · No fractional shares will be issued; holders otherwise entitled to a fractional share will receive one whole share rounded up.
• · The amendment becomes effective upon filing with the Florida Division of Corporations, expected July 10, 2026.

08-07-2026

Onfolio Holdings announced a binding LOI with Paramount Helium to acquire a senior debt position secured by helium and carbon dioxide assets in the St. Johns Unit in Arizona, targeting entry into the $122B global industrial gas market. The resource is estimated to hold over 20 billion cubic feet of helium (roughly 10x the size of the US Federal Helium Reserve) and includes the largest identified terrestrial deposit of Helium-3, valued at $10-20M per kg. However, the transaction is subject to definitive agreements, financing, and regulatory approvals, and Onfolio has no operating history in the industrial gas sector, presenting significant execution risk.

• · Helium-3 is a rare isotope critical to quantum computing, neutron detection, and nuclear fusion.
• · Proton Green's assets are located in northeastern Arizona (St. Johns Dome).
• · Paramount Helium has agreed terms with Proton Green's secured creditors to acquire the senior debt position.
• · Helium is not on the USGS critical minerals list but is considered strategically important by industry and policymakers.
• · Recent disruptions in Qatar (one-third of global supply) highlight supply chain vulnerability.
• · Potential customers include semiconductor manufacturers in Phoenix and space exploration companies in the western US.
• · The transaction is subject to negotiation of definitive agreements, financing, and regulatory approvals.
• · Onfolio has no prior experience in the industrial gas industry.

08-07-2026

Alkermes plc and Amneal Pharmaceuticals LLC terminated their Authorized Generic Product Supply Agreement for a generic version of VIVITROL® on July 6, 2026. The termination followed Alkermes' notification that Amneal had not met certain terms, and Amneal subsequently declined to order any batches. No penalties were incurred, and all claims between the parties have been released.

• · The agreement was originally entered into on September 9, 2025.
• · The agreement granted Amneal rights to distribute and sell a limited quantity of an authorized generic version of VIVITROL® in the U.S. for a one-year term starting from a Third Party ANDA Product Launch.
• · Amneal was to pay a premium to APIL's fully burdened manufacturing cost plus a share of Net Profits.
• · Alkermes notified Amneal of unmet terms, Amneal had a remedy period, but chose not to order any batches before the period expired.
• · No penalties were incurred by either party, and all claims have been released.

08-07-2026

Evolus, Inc. announced an exclusive licensing and distribution agreement with IBSA to develop and commercialize Profhilo® in the United States, expanding its injectable portfolio into the skin quality segment. Profhilo® is the market-leading injectable for skin quality in Europe with over 4.8 million treatments administered globally since 2015. The agreement involves no upfront payments and is not expected to impact Evolus' previously communicated 2026 or 2028 financial outlook, though the product still requires U.S. regulatory approval and faces commercialization risks.

• · Profhilo® is based on a unique hyaluronic acid formulation for superficial application to improve skin hydration, elasticity, and smoothness.
• · The U.S. injectable skin quality category is in early stages compared to Europe, representing a substantial growth opportunity.
• · The agreement uses a transfer-price model designed to support gross margins consistent with Evolus' long-term financial framework.
• · Evolus will be responsible for development activities required for U.S. regulatory approval and subsequent commercialization.
• · The agreement is not expected to impact Evolus' previously communicated 2026 revenue, operating expense, or operating profit outlook, nor its 2028 revenue or profitability targets.

08-07-2026

Sterling Infrastructure, Inc. announced the extension and expansion of its credit facility to $1.5 billion, with a maturity extended to July 2031. The new facility increases borrowing capacity by $1.05 billion compared to the existing credit facilities, providing additional financial flexibility for refinancing, capital expenditures, acquisitions, and general corporate purposes. The amendment also includes a larger incremental facility, reduced interest rates, and less restrictive covenants.

• · The credit facility maturity is extended to July 2031.
• · The syndication process resulted in new and expanded lender participation from a diversified group of leading national and regional financial institutions.
• · The facility will be used for refinancing and prepaying existing indebtedness, capital expenditures, permitted acquisitions, and other general corporate purposes.
• · The amendment eliminates the 10-basis point SOFR adjustment and reduces overall pricing margins based on Total Net Leverage Ratio.
• · Covenants are generally less restrictive under the amended facility.

08-07-2026

Brownie's Marine Group, Inc. acquired substantially all assets of Sunrise Paddleboards LLC through its wholly-owned subsidiary Live Blue, Inc. in exchange for 42,000,000 shares of common stock valued at $0.0044 per share. The acquisition expands Brownie's recreational offerings into paddleboarding and kayaking experiences, including rentals, tours, retail, and training.

• · The Consideration Shares were issued at a price of $0.0044 per share, based on the closing price of the Company's common stock on the OTC Markets on June 30, 2026.
• · The issuance of the Consideration Shares is exempt from registration under Section 4(a)(2) of the Securities Act of 1933.
• · The Asset Purchase Agreement includes schedules that have been omitted from the filing but will be furnished to the SEC upon request.
• · The acquisition was executed and consummated on July 1, 2026.

08-07-2026

Energy Transfer LP priced $1.75 billion in junior subordinated notes (Series 2026A: $650M at 6.550%, Series 2026B: $1.1B at 6.700%) due 2057, with net proceeds of approximately $1.7325 billion. The company intends to use the proceeds to redeem all outstanding 6.500% Series H Preferred Units (redeemable from August 15, 2026), refinance existing indebtedness, and for general partnership purposes. The offering is expected to settle on July 20, 2026.

• · The Series 2026A notes bear interest at 6.550% annually, and the Series 2026B notes at 6.700% annually.
• · The notes are priced at 100.000% of face value.
• · The offering is expected to settle on July 20, 2026.
• · The redemption period for Series H Preferred Units commences August 15, 2026.
• · Energy Transfer owns approximately 28 million common units of Sunoco LP (15% of aggregate outstanding common and Class D units) and approximately 46 million common units of USA Compression Partners (32% of outstanding common units).
• · The company operates approximately 140,000 miles of pipeline across 44 states.